Madrigal Pharmaceuticals, Inc. (BIT:1MDGL)

Italy flag Italy · Delayed Price · Currency is EUR
430.20
0.00 (0.00%)
Last updated: Jan 20, 2026, 9:00 AM CET
55.98%
Market Cap9.65B
Revenue (ttm)631.25M
Net Income (ttm)-246.42M
Shares Outn/a
EPS (ttm)-11.11
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Average Volume1
Open430.20
Previous Close430.20
Day's Range430.20 - 430.20
52-Week Range237.50 - 518.20
Betan/a
RSI37.70
Earnings DateFeb 25, 2026

About Madrigal Pharmaceuticals

Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company is headquartered in West Conshohocken, Pennsylvania. [Read more]

Industry Pharmaceutical Preparations
CEO William Sibold
Employees 528
Stock Exchange Borsa Italiana
Ticker Symbol 1MDGL
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements